--- title: "Xinde New Material: In the third quarter, the net profit attributable to the parent company was 20.9084 million yuan, a year-on-year increase of 405.28%" type: "News" locale: "en" url: "https://longbridge.com/en/news/262761552.md" description: "On October 26th, Xinde New Material announced that it achieved operating revenue of 332 million yuan in the third quarter of 2025, a year-on-year increase of 62.40%; the net profit attributable to shareholders of the listed company was 20.9084 million yuan, a year-on-year increase of 405.28%; basic earnings per share were 0.2072 yuan" datetime: "2025-10-26T08:56:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262761552.md) - [en](https://longbridge.com/en/news/262761552.md) - [zh-HK](https://longbridge.com/zh-HK/news/262761552.md) --- # Xinde New Material: In the third quarter, the net profit attributable to the parent company was 20.9084 million yuan, a year-on-year increase of 405.28% On October 26th, Xinde New Material announced that it achieved an operating income of 332 million yuan in the third quarter of 2025, a year-on-year increase of 62.40%; the net profit attributable to shareholders of the listed company was 20.9084 million yuan, a year-on-year increase of 405.28%; the basic earnings per share were 0.2072 yuan ### Related Stocks - [301349.CN](https://longbridge.com/en/quote/301349.CN.md) ## Related News & Research - [Stocks to buy: Tata Communications, Nibe, ELGI Equipments on analyst radar](https://longbridge.com/en/news/287141880.md) - [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md) - [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md) - [CEMATRIX Announces $4.1 Million in New Contract Awards | CTXXF Stock News](https://longbridge.com/en/news/287120486.md) - [09:01 ETMedscape Partners with City of Hope to Enhance Oncology Content and Insights for Clinicians Worldwide](https://longbridge.com/en/news/287070736.md)